Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients? is a research paper published in JNCI Journal of the National Cancer Institute (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute Cancer Center
Grant: P30 CA008748
NIH HHS
National Institutes of Health
Breast Cancer Research Foundation
MeSH Terms